Companies: 10,795·Total market cap: $144.5T
NovaBridge Biosciences

NovaBridge Biosciences

NBPNASDAQHealthcare● Active
$1.56
$-0.09(-5.17%)
Market Cap$179815043
P/E Ratio
52W High$6.79
52W Low$1.53

NovaBridge Biosciences(NBP)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · NBP · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.00B($0.01B)$0.09B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.05B
Gross Profit$0.00B$0.00B$0.00B($0.01B)$0.04B
Gross Margin %(computed)100.00%100.00%47.25%
Operating Expenses
R&D Expenses$0.01B$0.16B$0.11B$0.16B$0.19B
G&A Expenses$0.00B$0.22B$0.06B$0.20B$0.90B
Total Operating Expenses$0.01B$0.38B$0.52B$0.36B$2.11B
Operating Income($0.01B)($0.38B)($0.51B)($0.37B)($2.07B)
Operating Margin %(computed)
Interest Income$0.00B$0.05B$0.01B$0.00B$0.02B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.01B)($0.36B)($1.47B)($0.97B)($2.33B)
Income Tax Expense$0.00B$0.00B($1.26B)$0.00B($0.00B)
Net Income($0.01B)($0.16B)($1.47B)($2.51B)($2.33B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-0.16$-4.46$-17.62$-30.38$-30.70
Wtd Avg Shares0.04B0.08B0.08B0.08B0.08B
EBITDA($0.01B)($0.37B)($0.34B)($0.05B)($2.06B)
EBITDA Margin %(computed)478.91%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解NovaBridge Biosciences

关于NovaBridge Biosciences(NBP)损益表

NovaBridge Biosciences(NBP)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,NBP实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.01B)(净利率—)。

常见问题

NBP · 4 问

NovaBridge Biosciences(NBP)2025财年营收为$0.00B,同比down—%。

NBP revenueNBP salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09